Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide

J Neurochem. 2003 Dec;87(5):1145-51. doi: 10.1046/j.1471-4159.2003.02098.x.

Abstract

In glutamate-mediated excitatory neuronal cell death, immunosuppressants (FK506, Cys-A) are powerful agents that protect neurons from apoptosis. Immunosuppressants inhibit two types of enzyme, calcium/calmodulin-dependent protein phosphatase (calcineurin: CaN), and peptidyl-prolyl cis-trans-isomerase (PPIase) activity such as the FKBP family. In this study, we used a protein transduction approach to determine the functional role of CaN and to produce a potential therapeutic agent for glutamate-mediated neuronal cell death. We created a novel cell-permeable CaN autoinhibitory peptide using the 11 arginine protein transduction domain. This peptide was highly efficient at transducing into primary culture neurons, potently inhibited CaN phosphatase activities, and inhibited glutamate-mediated neuronal cell death. These results showed that CaN plays an important role in excitatory neuronal cell death and cell-permeable CaN autoinhibitory peptide could be a new drug to protect neurons from excitatory neuronal death.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Biological Transport / drug effects
  • Biological Transport / physiology
  • Calcineurin Inhibitors*
  • Cell Membrane / metabolism
  • Cells, Cultured
  • DNA-Binding Proteins / genetics
  • Enzyme Inhibitors / metabolism
  • Enzyme Inhibitors / pharmacokinetics
  • Enzyme Inhibitors / pharmacology*
  • Genes, Reporter
  • Glutamic Acid / toxicity
  • Green Fluorescent Proteins
  • Hippocampus / cytology
  • Luminescent Proteins / genetics
  • NFATC Transcription Factors
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / pharmacology
  • Nuclear Proteins*
  • Peptides / metabolism
  • Peptides / pharmacokinetics
  • Peptides / pharmacology*
  • Promoter Regions, Genetic / drug effects
  • Protein Structure, Tertiary / genetics
  • Protein Structure, Tertiary / physiology
  • Rats
  • Rats, Wistar
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Transcription Factors / genetics

Substances

  • Calcineurin Inhibitors
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Luminescent Proteins
  • NFATC Transcription Factors
  • Neuroprotective Agents
  • Nuclear Proteins
  • Peptides
  • Recombinant Fusion Proteins
  • Transcription Factors
  • Green Fluorescent Proteins
  • Glutamic Acid